Federal grants to Reselute, Inc.
Reselute, Inc. in Durham, North Carolina received $1.6 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Technology, Innovation, and Partnerships, with $1.0 million. In fiscal 2025 it was awarded $314,362.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$1.6 million
- Awards4
- Awarded in FY 2025$314,362
- Largest award$998,921
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 2 | $275,247 |
| FY 2023 | 0 | $0 |
| FY 2024 | 1 | $998,921 |
| FY 2025 | 1 | $314,362 |
Programs that fund Reselute, Inc.
| Program | Awards | Amount |
|---|---|---|
| Technology, Innovation, and Partnerships | 2 | $1.0 million |
| Arthritis, Musculoskeletal and Skin Diseases Research | 1 | $314,362 |
| Engineering | 1 | $255,247 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| National Science Foundation | 3 | $1.3 million |
| Department of Health and Human Services | 1 | $314,362 |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Sttr phase II: development of a antibiotic releasing intramedullary nail for treatment of fracture related infections -the broader impact/commercial potential of this small business technology transfer (STTR) phase II project is a novel implantable orthopedic medical device and procedure to reduce t | Technology, Innovation, and Partnerships | July 15, 2024 | $998,921 |
| Local and sustained release of antibiotics in the surgical treatment of diabetic charcot foot - charcot osteoarthropathy (COA), a severe complication of diabetes mellitus, often leads to destructive bone and joint degeneration, significant deformity, and increased risk of amputation. Surgical interv | Arthritis, Musculoskeletal and Skin Diseases Research | September 3, 2025 | $314,362 |
| Sbir phase i: localized and sustained antibiotic delivery for treatment of periprosthetic joint infection (PJI) in arthroplasty patients -the broader impact of this small business innovation research (SBIR) phase i project is develop an innovative medical technology for localized and sustained antib | Engineering | February 5, 2022 | $255,247 |
| Sbir phase i: localized and sustained antibiotic delivery for treatment of periprosthetic joint infection (PJI) in arthroplasty patients -the broader impact of this small business innovation research (SBIR) phase i project is develop an innovative medical technology for localized and sustained antib | Technology, Innovation, and Partnerships | June 22, 2022 | $20,000 |
Questions people ask
How much federal grant money does Reselute, Inc. get?
$1.6 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Reselute, Inc. the most?
The National Science Foundation, with $1.3 million in 3 awards. The Department of Health and Human Services follow.
What is Reselute, Inc.'s largest federal grant?
$998,921 under Technology, Innovation, and Partnerships, with its first action in the period on July 15, 2024. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Reselute, Inc.?
Its largest are Technology, Innovation, and Partnerships, Arthritis, Musculoskeletal and Skin Diseases Research and Engineering.
Other grant recipients in Durham
- Duke University
- Family Health International
- North Carolina Central University
- Housing Authority of the City of Durham
- Rho Federal Systems Division Inc
- City of Durham
- Families & Communities Rising, Inc.
- Lincoln Community Health Center Incorporated
Largest federal grant recipients in North Carolina · Federal grants in North Carolina